Page last updated: 2024-08-23

etoposide and Bone Loss, Perimenopausal

etoposide has been researched along with Bone Loss, Perimenopausal in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Cui, K; Li, D; Wang, W; Wang, Y; Zhao, H; Zhu, Y	1

Other Studies

1 other study(ies) available for etoposide and Bone Loss, Perimenopausal

Article	Year
Bushen Ningxin Decoction pharmacological serum promotes the proliferation and suppresses the apoptosis of murine osteoblasts through MAPK pathway. Journal of ethnopharmacology, 2009, Mar-18, Volume: 122, Issue:2 Topics: Animals; Apoptosis; Bone and Bones; Bone Density Conservation Agents; Cell Proliferation; Disease Models, Animal; Drugs, Chinese Herbal; eIF-2 Kinase; Etoposide; Female; Humans; Magnoliopsida; MAP Kinase Signaling System; Mice; Mice, Inbred BALB C; Osteoblasts; Osteoporosis, Postmenopausal; Ovariectomy; Phytotherapy	2009

Article

Year

Bushen Ningxin Decoction pharmacological serum promotes the proliferation and suppresses the apoptosis of murine osteoblasts through MAPK pathway.

Journal of ethnopharmacology, 2009, Mar-18, Volume: 122, Issue:2

Topics: Animals; Apoptosis; Bone and Bones; Bone Density Conservation Agents; Cell Proliferation; Disease Models, Animal; Drugs, Chinese Herbal; eIF-2 Kinase; Etoposide; Female; Humans; Magnoliopsida; MAP Kinase Signaling System; Mice; Mice, Inbred BALB C; Osteoblasts; Osteoporosis, Postmenopausal; Ovariectomy; Phytotherapy

2009